These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 22738931)

  • 1. The role of cytokines in the pathogenesis and treatment of HIV infection.
    Catalfamo M; Le Saout C; Lane HC
    Cytokine Growth Factor Rev; 2012; 23(4-5):207-14. PubMed ID: 22738931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine production and dysregulation in HIV pathogenesis: lessons for development of therapeutics and vaccines.
    Reuter MA; Pombo C; Betts MR
    Cytokine Growth Factor Rev; 2012; 23(4-5):181-91. PubMed ID: 22743036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell exhaustion in HIV infection.
    Fenwick C; Joo V; Jacquier P; Noto A; Banga R; Perreau M; Pantaleo G
    Immunol Rev; 2019 Nov; 292(1):149-163. PubMed ID: 31883174
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of extended-release niacin on immune activation and neurocognition in HIV-infected patients treated with antiretroviral therapy - CTN PT006: study protocol for a randomized controlled trial.
    Lebouché B; Jenabian MA; Singer J; Graziani GM; Engler K; Trottier B; Thomas R; Brouillette MJ; Routy JP
    Trials; 2014 Oct; 15():390. PubMed ID: 25293882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of functional impairment with inflammation and immune activation in HIV type 1-infected adults receiving effective antiretroviral therapy.
    Erlandson KM; Allshouse AA; Jankowski CM; Lee EJ; Rufner KM; Palmer BE; Wilson CC; MaWhinney S; Kohrt WM; Campbell TB
    J Infect Dis; 2013 Jul; 208(2):249-59. PubMed ID: 23559466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between the size of HIV proviral DNA reservoir and the level of immune activation in HIV-infected patients with a sustained undetectable HIV viral load for 10 years.
    Poizot-Martin I; Faucher O; Obry-Roguet V; Nicolino-Brunet C; Ronot-Bregigeon S; Dignat-George F; Tamalet C
    J Clin Virol; 2013 Aug; 57(4):351-5. PubMed ID: 23664725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of CD4:CD8 ratio normalization and its effect on health outcomes in the era of combination antiretroviral therapy.
    Leung V; Gillis J; Raboud J; Cooper C; Hogg RS; Loutfy MR; Machouf N; Montaner JS; Rourke SB; Tsoukas C; Klein MB;
    PLoS One; 2013; 8(10):e77665. PubMed ID: 24204912
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasticity of the Immune System in Children Following Treatment Interruption in HIV-1 Infection.
    Sandgaard KS; Margetts B; Attenborough T; Gkouleli T; Adams S; Holm M; Gibb D; Gibbons D; Giaquinto C; De Rossi A; Bamford A; Palma P; Chain B; Gkazi AS; Klein N
    Front Immunol; 2021; 12():643189. PubMed ID: 34475868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-Related Immune Activation and Inflammation: Current Understanding and Strategies.
    Lv T; Cao W; Li T
    J Immunol Res; 2021; 2021():7316456. PubMed ID: 34631899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reconstitution of EBV latent but not lytic antigen-specific CD4+ and CD8+ T cells after HIV treatment with highly active antiretroviral therapy.
    Piriou E; Jansen CA; van Dort K; De Cuyper I; Nanlohy NM; Lange JM; van Oers MH; Miedema F; van Baarle D
    J Immunol; 2005 Aug; 175(3):2010-7. PubMed ID: 16034146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural killer cell counts in primary HIV infection predicts disease progression and immune restoration after treatment.
    Wang Y; Zhang Y; Tang T; Zhao W; Fu S; Zhang Z; Fu Y; Xu J; Ding H; Han X; Jiang Y
    Virology; 2020 Nov; 550():89-98. PubMed ID: 32920454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Harnessing CD8
    Warren JA; Clutton G; Goonetilleke N
    Front Immunol; 2019; 10():291. PubMed ID: 30863403
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interferon-alpha administration enhances CD8+ T cell activation in HIV infection.
    Manion M; Rodriguez B; Medvik K; Hardy G; Harding CV; Schooley RT; Pollard R; Asmuth D; Murphy R; Barker E; Brady KE; Landay A; Funderburg N; Sieg SF; Lederman MM
    PLoS One; 2012; 7(1):e30306. PubMed ID: 22291932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Tat immunity defines CD4
    Tripiciano A; Picconi O; Moretti S; Sgadari C; Cafaro A; Francavilla V; Arancio A; Paniccia G; Campagna M; Pavone-Cossut MR; Sighinolfi L; Latini A; Mercurio VS; Pietro MD; Castelli F; Saracino A; Mussini C; Perri GD; Galli M; Nozza S; Ensoli F; Monini P; Ensoli B
    EBioMedicine; 2021 Apr; 66():103306. PubMed ID: 33839064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation and lysis of human CD4 cells latently infected with HIV-1.
    Pegu A; Asokan M; Wu L; Wang K; Hataye J; Casazza JP; Guo X; Shi W; Georgiev I; Zhou T; Chen X; O'Dell S; Todd JP; Kwong PD; Rao SS; Yang ZY; Koup RA; Mascola JR; Nabel GJ
    Nat Commun; 2015 Oct; 6():8447. PubMed ID: 26485194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of CD31 expression in CD4+ and CD8+T cell subpopulations in chronic untreated HIV infection.
    Briceño O; Peralta-Prado A; Garrido-Rodríguez D; Romero-Mora K; Chávez-Torres M; de la Barrera CA; Reyes-Terán G; Ávila-Ríos S
    Immunol Lett; 2021 Jul; 235():22-31. PubMed ID: 33852965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of immune complexes and plasma viral load with CD4+ cell depletion, CD8+ DR+ and CD16+ cell counts in HIV+ hemophilia patients. Implications for the immunopathogenesis of HIV-induced CD4+ lymphocyte depletion.
    Daniel V; Süsal C; Weimer R; Zimmermann R; Huth-Kühne A; Opelz G
    Immunol Lett; 2001 Mar; 76(2):69-78. PubMed ID: 11274723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. HIV Controllers Exhibit Effective CD8
    Monel B; McKeon A; Lamothe-Molina P; Jani P; Boucau J; Pacheco Y; Jones RB; Le Gall S; Walker BD
    Cell Rep; 2019 Apr; 27(1):142-153.e4. PubMed ID: 30943397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD4 and CD8 T cell immune activation during chronic HIV infection: roles of homeostasis, HIV, type I IFN, and IL-7.
    Catalfamo M; Wilhelm C; Tcheung L; Proschan M; Friesen T; Park JH; Adelsberger J; Baseler M; Maldarelli F; Davey R; Roby G; Rehm C; Lane C
    J Immunol; 2011 Feb; 186(4):2106-16. PubMed ID: 21257970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.